{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T19:53:15Z","timestamp":1782503595403,"version":"3.54.5"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,27]]},"DOI":"10.7759\/cureus.81270","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T09:18:24Z","timestamp":1743067104000},"source":"Crossref","is-referenced-by-count":4,"title":["Recurrent Aggressive Angiomyxoma That Responded to the Gonadotropin-Releasing Hormone (GnRH) Antagonist Relugolix"],"prefix":"10.7759","author":[{"given":"Arisa","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Komiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoki","family":"Kugimiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahumi","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-198307000-00009","article-title":"Aggressive angiomyxoma of the female pelvis and perineum: report of nine cases of a distinctive type of gynecologic soft-tissue neoplasm","volume":"7","author":"Steeper TA","year":"1983","unstructured":"Steeper TA, Rosai J. Aggressive angiomyxoma of the female pelvis and perineum: report of nine cases of a distinctive type of gynecologic soft-tissue neoplasm. Am J Surg Pathol. 1983, 7:463-75. 10.1097\/00000478-198307000-00009","journal-title":"Am J Surg Pathol"},{"key":"ref2","article-title":"Aggressive angiomyxoma of the vulva in pregnancy: a case report and review of management options","volume":"9","author":"Bagga R","year":"2007","unstructured":"Bagga R, Keepanasseril A, Suri V, Nijhawan R. Aggressive angiomyxoma of the vulva in pregnancy: a case report and review of management options. MedGenMed. 2007, 9:16.","journal-title":"MedGenMed"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2023.966971","article-title":"Characteristics and treatment strategies of aggressive angiomyxoma in women: a retrospective review of 87 cases","volume":"10","author":"Wang Y","year":"2023","unstructured":"Wang Y, Bu X, Liu Y, Xing Y, Tong Q. Characteristics and treatment strategies of aggressive angiomyxoma in women: a retrospective review of 87 cases. Front Surg. 2023, 10:966971. 10.3389\/fsurg.2023.966971","journal-title":"Front Surg"},{"key":"ref4","article-title":"Aggressive angiomyxoma in females: is radical resection the only option?","volume":"79","author":"Chan YM","year":"2000","unstructured":"Chan YM, Hon E, Ngai SW, Ng TY, Wong LC. Aggressive angiomyxoma in females: is radical resection the only option?. Acta Obstet Gynecol Scand. 2000, 79:216-20.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520936414","article-title":"Aggressive angiomyxoma in pregnancy: a case report and literature review","volume":"48","author":"Xu H","year":"2020","unstructured":"Xu H, Sun P, Xu R, Wang L, Shi Y. Aggressive angiomyxoma in pregnancy: a case report and literature review. J Int Med Res. 2020, 48:300060520936414. 10.1177\/0300060520936414","journal-title":"J Int Med Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.172.2.9930798","article-title":"Aggressive angiomyxoma: findings on CT and MR imaging","volume":"172","author":"Outwater EK","year":"1999","unstructured":"Outwater EK, Marchetto BE, Wagner BJ, Siegelman ES. Aggressive angiomyxoma: findings on CT and MR imaging. AJR Am J Roentgenol. 1999, 172:435-8. 10.2214\/ajr.172.2.9930798","journal-title":"AJR Am J Roentgenol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.53.8.603","article-title":"Aggressive angiomyxoma of pelvic parts exhibits oestrogen and progesterone receptor positivity","volume":"53","author":"McCluggage WG","year":"2000","unstructured":"McCluggage WG, Patterson A, Maxwell P. Aggressive angiomyxoma of pelvic parts exhibits oestrogen and progesterone receptor positivity. J Clin Pathol. 2000, 53:603-5. 10.1136\/jcp.53.8.603","journal-title":"J Clin Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/jscr\/rjaa330","article-title":"Aggressive angiomyxoma persistently misdiagnosed as an obturator hernia managed with resection and hormonal therapy: case report","volume":"2020","author":"Alomary NA","year":"2020","unstructured":"Alomary NA, Albeeshi MZ, Al Thebaity RE, Yousef ZM, El-Boghdadly SA. Aggressive angiomyxoma persistently misdiagnosed as an obturator hernia managed with resection and hormonal therapy: case report. J Surg Case Rep. 2020, 2020:rjaa330. 10.1093\/jscr\/rjaa330","journal-title":"J Surg Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2000.6119","article-title":"Primary medical management of recurrent aggressive angiomyxoma of the vulva with a gonadotropin-releasing hormone agonist","volume":"81","author":"Fine BA","year":"2001","unstructured":"Fine BA, Munoz AK, Litz CE, Gershenson DM. Primary medical management of recurrent aggressive angiomyxoma of the vulva with a gonadotropin-releasing hormone agonist. Gynecol Oncol. 2001, 81:120-2. 10.1006\/gyno.2000.6119","journal-title":"Gynecol Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2018-0338","article-title":"Treatment outcomes and sensitivity to hormone therapy of aggressive angiomyxoma: a multicenter, international, retrospective study","volume":"24","author":"Fuc\u00e0 G","year":"2019","unstructured":"Fuc\u00e0 G, Hindi N, Ray-Coquard I, et al.. Treatment outcomes and sensitivity to hormone therapy of aggressive angiomyxoma: a multicenter, international, retrospective study. Oncologist. 2019, 24:e536-41. 10.1634\/theoncologist.2018-0338","journal-title":"Oncologist"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.diii.2013.01.009","article-title":"Aggressive angiomyxoma","volume":"94","author":"Gay F","year":"2013","unstructured":"Gay F, Champigneulle J, Tortuyaux JM, Cuny T, R\u00e9gent D, Laurent-Crois\u00e9 V. Aggressive angiomyxoma. Diagn Interv Imaging. 2013, 94:657-61. 10.1016\/j.diii.2013.01.009","journal-title":"Diagn Interv Imaging"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4419","article-title":"Pelvic aggressive angiomyxoma: major challenges in diagnosis and treatment","volume":"11","author":"Hajjar R","year":"2019","unstructured":"Hajjar R, Alharthi M, Richard C, Gougeon F, Loungnarath R. Pelvic aggressive angiomyxoma: major challenges in diagnosis and treatment. Cureus. 2019, 11:e4419. 10.7759\/cureus.4419","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2004.00816.x","article-title":"Medical management of recurrent aggressive angiomyxoma with gonadotropin-releasing hormone agonist","volume":"11","author":"Shinohara N","year":"2004","unstructured":"Shinohara N, Nonomura K, Ishikawa S, Seki H, Koyanagi T. Medical management of recurrent aggressive angiomyxoma with gonadotropin-releasing hormone agonist. Int J Urol. 2004, 11:432-5. 10.1111\/j.1442-2042.2004.00816.x","journal-title":"Int J Urol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003141","article-title":"Oral gonadotropin-releasing hormone antagonist relugolix compared with leuprorelin injection for uterine leiomyomas: a randomizes controlled trial","volume":"133","author":"Osuga Y","year":"2019","unstructured":"Osuga Y, Enya K, Kudou K, Tanimoto M, Hoshiai H. Oral gonadotropin-releasing hormone antagonist relugolix compared with leuprorelin injection for uterine leiomyomas: a randomizes controlled trial. Obstet Gynecol. 2019, 133:423-33. 10.1097\/AOG.0000000000003141","journal-title":"Obstet Gynecol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2020.8989","article-title":"Bone mineral density changes associated with pregnancy, lactation, and medical treatments in premenopausal women and effects later in life","volume":"30","author":"Watts NB","year":"2021","unstructured":"Watts NB, Binkley N, Owens CD, et al.. Bone mineral density changes associated with pregnancy, lactation, and medical treatments in premenopausal women and effects later in life. J Womens Health (Larchmt). 2021, 30:1416-30. 10.1089\/jwh.2020.8989","journal-title":"J Womens Health (Larchmt)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/352334-recurrent-aggressive-angiomyxoma-that-responded-to-the-gonadotropin-releasing-hormone-gnrh-antagonist-relugolix","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T09:18:39Z","timestamp":1743067119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/352334-recurrent-aggressive-angiomyxoma-that-responded-to-the-gonadotropin-releasing-hormone-gnrh-antagonist-relugolix"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.81270","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,27]]}}}